Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Maternal and Fetal Serum Soluble Fms-like Tyrosine Kinase-1, Seromucoid, and Protein-bound Hexose in Women With Pre-eclampsia: A Case-control Study

NCT06712550 is registered in ClinicalTrials.gov with SHAHLA KAREEM ALALAF as lead sponsor.

NCT NCT06712550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06712550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Maternal and Fetal Serum Soluble Fms-like Tyrosine Kinase-1, Seromucoid, and Protein-bound Hexose in Women With Pre-eclampsia: A Case-control Study
Lead sponsor
SHAHLA KAREEM ALALAF
Phase
Observational
Overall status
Completed
Start date
December 13, 2024
Completion date
July 12, 2025
Enrollment
204 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory markers, inflammatory response, preeclampsia mild, preeclampsia severe, protein-bound hexose in preeclampsia, serum seromucoid in pregnancy, umbilical cord issue